REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro Urologico Foscal Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Centro Urologico Foscal Sas Profile Updated: April 08, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Centro Urologico Foscal Sas is a company in Colombia, with a head office in Floridablanca. The company operates in the Ambulatory Health Care Services industry. Centro Urologico Foscal Sas was incorporated on October 05, 2004. It currently has a total number of 15 (2026) employees. There was a net sales revenue increase of 15.84% reported in Centro Urologico Foscal Sas’s latest financial highlights for 2025. Its total assets grew by 13.86% over the same period. In, 2025, the company’s net profit margin decreased by 3.6%.

Headquarters
Centro Medico Carlos Ardila Lulle Piso 10 Modulo 62 Torre B
Floridablanca; Santander;

Contact Details: Purchase the Centro Urologico Foscal Sas report to view the information.

Basic Information
Total Employees:
Purchase the Centro Urologico Foscal Sas report to view the information.
Registered Capital:
Purchase the Centro Urologico Foscal Sas report to view the information.
Financial Auditors:
Purchase the Centro Urologico Foscal Sas report to view the information.
Incorporation Date:
October 05, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro Urologico Foscal Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
15.84%
Total Operating Revenue
15.84%
Operating Profit
-2.89%
EBITDA
-2.49%
Net Profit/Loss for the Period
-14.61%
Total Assets
13.86%
Total Equity
14.29%
Operating Profit Margin
-3.09%
Net Profit Margin
-3.6%
Return on Equity (ROE)
-4.3%
Debt / Equity
-2.36%
Quick Ratio
0.26%
Cash Ratio
0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?